Crossmark

Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial

Crossref DOI link: https://doi.org/10.1186/s12876-018-0805-z

Published Online: 2018-06-04

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Friedrich, Dana http://orcid.org/0000-0003-0873-3818
Marschall, Hanns-Ulrich

Lammert, Frank
License Information

Text and Data Mining valid from 2018-06-04
More Information

Article History

Received: 7 November 2016

Accepted: 23 May 2018

First Online: 4 June 2018

Ethics approval and consent to participate

: The study protocol was approved by the Ethics Committee of the Ärztekammer des Saarlandes, Saarbrücken (ID number 58/09). All subjects (≥ 18 years) were fully informed about the study objectives and methods and gave their written informed consent before participating in this non-randomized controlled pilot trial.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below